Acute coronary syndromes
Trovati 15 articoli
- Coronary stents: Prasugrel may reduce ischaemic outcomes, including stent thrombosis
- Prasugrel ( Efient, Effient ), a new antiplatelet agent that provides higher levels of platelet inhibition than current standard therapies, could provide more consistent protection from ischemic events than standard treatment in patients who have had at least one coronary stent. Narrowing or b... (Leggi Articolo)
- Young myocardial infarction survivors: smoking is greatest predictor of recurrent cardiac events
- Continuing to smoke following a myocardial infarction is the most powerful predictor for recurrent cardiac events among survivors age 35 years or younger. In particular, patients who continue to smoke have approximately three times the risk for future heart problems ( e.g., cardiac death, a rep... (Leggi Articolo)
- Acute myocardial infarction: drug eluting stents should be used with caution
- Drug-eluting stents ( DES ) are extremely effective devices to prevent restenosis following angioplasty. Yet, since last year, there is some debate and persistent uncertainty regarding the long term safety of these devices. Specifically, there is concern that some of these stents may occlude abru... (Leggi Articolo)
- CSL-11, a drug that mimics HDL, has mixed effect on coronary atherosclerosis
- Patients with acute coronary syndromes ( ACS ), such as heart attack and recent-onset chest pain, remain at considerable risk of experiencing further serious cardiovascular problems despite improvements in care. HDL has properties that may protect these patients from further complications by re... (Leggi Articolo)
- Treating depression may reduce cardiac risk in patients with acute coronary syndrome
- Patients with depression appear to have an impaired ability to recover their heart rate variability ( HRV ) following acute coronary syndromes, a factor that could increase their risk of coronary death. However, patients who are treated with antidepressants or whose mood lifts may experience mor... (Leggi Articolo)
- Acute coronary syndrome: recommended treatments linked with reductions in rates of heart failure, stroke, heart attack and death
- Recent changes in the recommended treatments used for patients hospitalized for acute coronary syndromes are associated with reductions in the rates of heart failure, stroke, myocardial infarction and death. Randomized trials have provided strong evidence for the effectiveness of pharmacologic... (Leggi Articolo)
- Caffeine limits blood flow to heart muscle during exercise
- In healthy volunteers, the equivalent of two cups of coffee reduced the body's ability to boost blood flow to the heart muscle in response to exercise, and the effect was stronger when the participants were in a chamber simulating high altitude. The study is published in the Journal of America... (Leggi Articolo)
- Angiomax alone reduces a significant number of major bleeding episodes in acute coronary syndrome
- The ACUITY ( Acute Catheterization and Urgent Intervention Triage strategy ) trial has assessed the potential of the injectable anti-clotting medicine Bivalirudin ( Angiomax ) in patients experiencing cardiac emergencies known as acute coronary syndromes ( ACS ). The results have shown that Bi... (Leggi Articolo)
- Acute coronary syndromes, adherence to treatment guidelines declines as patient age increases
- A review of more than 56,000 cases of acute coronary syndromes reveals that older patients are less likely to receive treatment recommended by guidelines, even though they benefit as much or more than younger patients when the recommended treatment is provided. " Our study is unique in that it... (Leggi Articolo)
- Very low LDL cholesterol levels appear to be safe for patients on intensive therapy
- Very low LDL cholesterol levels appear to be safe for heart patients on statin therapies. " There was no apparent safety concern for patients whose resultant LDL on intensive therapy was lower than current guidelines. There was a trend toward improved clinical outcomes in the lowest LDL group... (Leggi Articolo)
- Non-ST segment elevation acute coronary syndromes: better results with triple antiplatelet pre-treatment
- Aspirin and Clopidogrel ( Plavix ) are platelet antiaggregant drugs widely used and proven to be effective in the treatment of an acute coronary syndrome ( ACS ). High-risk patients with non-ST segment elevation acute coronary syndrome ( NSTE ACS ) benefit from the addition of glycoprotein ( GP ... (Leggi Articolo)
- Lovenox and unfractionated Heparin show similar outcomes at one year in acute coronary syndromes
- A study, published in the JAMA, showed that high-risk patients with acute coronary syndromes ( ACS ) treated with an early revascularization strategy and Enoxaparin ( Clexane / Lovenox ) or unfractionated Heparin at the time of hospitalization for ACS had similar outcomes at one year, including ... (Leggi Articolo)
- Excessive doses of antithrombotic therapy in patients with acute coronary syndromes
- A prospective observational analysis, coordinated by the DCRI ( Duke Clinical Research Institute ), in 387 US hospitals of 30,136 patients from the CRUSADE database has found that patients with NSTE ACS (non–ST-segment elevation acute coronary syndromes ) treated in the community often receive e... (Leggi Articolo)
- Morphine linked to higher mortality in acute coronary syndromes
- An analysis by researchers from the Duke Clinical Research Institute has shown that patients hospitalized for non–ST-segment elevation acute coronary syndromes ( NSTE ACS ) and treated with Morphine to relieve chest pain, have almost a 50 percent higher risk of dying. In the analysis of the ... (Leggi Articolo)
- Zocor did not achieve the prespecified end point in A to Z study - phase Z
- The Aggrastat to Zocor study, or A to Z study, phase Z has assessed whether early intensive Simvastatin ( Zocor ) treatment had advantages over a delayed conservative Simvastatin strategy in ACS ( acute coronary syndromes ) patients. A total of 4497 ACS patients ( ST-segment elevation MI [ST... (Leggi Articolo)
